Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Prostate Cancer

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 217 articles: HTML format

Single Articles

May 2008
1. MIYAJIMA N , Maruyama S, Bohgaki M, Kano S, et al
   TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells.
   Cancer Res. 2008;68:3486-94.
   PubMed     Related articles    Abstract available
   
   
   
2. PARK SI , Zhang J, Phillips KA, Araujo JC, et al
   Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model.
   Cancer Res. 2008;68:3323-33.
   PubMed     Related articles    Abstract available
   
   
   
3. HERMANS KG , Bressers AA, van der Korput HA, Dits NF, et al
   Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer.
   Cancer Res. 2008;68:3094-8.
   PubMed     Related articles    Abstract available
   
   
   April 2008
4. KOBAYASHI N , Barnard RJ, Said J, Hong-Gonzalez J, et al
   Effect of low-fat diet on development of prostate cancer and Akt phosphorylation in the Hi-Myc transgenic mouse model.
   Cancer Res. 2008;68:3066-73.
   PubMed     Related articles    Abstract available
   
   
   
5. HYER ML , Shi R, Krajewska M, Meyer C, et al
   Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancer.
   Cancer Res. 2008;68:2927-33.
   PubMed     Related articles    Abstract available
   
   
   
6. MAJID S , Kikuno N, Nelles J, Noonan E, et al
   Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification.
   Cancer Res. 2008;68:2736-44.
   PubMed     Related articles    Abstract available
   
   
   
7. WANG LG , Johnson EM, Kinoshita Y, Babb JS, et al
   Androgen receptor overexpression in prostate cancer linked to Pur alpha loss from a novel repressor complex.
   Cancer Res. 2008;68:2678-88.
   PubMed     Related articles    Abstract available
   
   
   
8. GRAHAM TR , Zhau HE, Odero-Marah VA, Osunkoya AO, et al
   Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells.
   Cancer Res. 2008;68:2479-88.
   PubMed     Related articles    Abstract available
   
   
   
9. KELLY KA , Setlur SR, Ross R, Anbazhagan R, et al
   Detection of early prostate cancer using a hepsin-targeted imaging agent.
   Cancer Res. 2008;68:2286-91.
   PubMed     Related articles    Abstract available
   
   
   
10. REN A , Yan G, You B, Sun J, et al
    Down-regulation of mammalian sterile 20-like kinase 1 by heat shock protein 70 mediates cisplatin resistance in prostate cancer cells.
    Cancer Res. 2008;68:2266-74.
    PubMed     Related articles    Abstract available
    
    
    
11. OUYANG X , Jessen WJ, Al-Ahmadie H, Serio AM, et al
    Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer.
    Cancer Res. 2008;68:2132-44.
    PubMed     Related articles    Abstract available
    
    
    
12. PEARSON HB , McCarthy A, Collins CM, Ashworth A, et al
    Lkb1 deficiency causes prostate neoplasia in the mouse.
    Cancer Res. 2008;68:2223-32.
    PubMed     Related articles    Abstract available
    
    
    
13. YAMASHITA S , Takahashi S, McDonell N, Watanabe N, et al
    Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers.
    Cancer Res. 2008;68:2112-21.
    PubMed     Related articles    Abstract available
    
    
    March 2008
14. LAKSHMAN M , Xu L, Ananthanarayanan V, Cooper J, et al
    Dietary genistein inhibits metastasis of human prostate cancer in mice.
    Cancer Res. 2008;68:2024-32.
    PubMed     Related articles    Abstract available
    
    
    
15. MCCABE CD , Spyropoulos DD, Martin D, Moreno CS, et al
    Genome-wide analysis of the homeobox C6 transcriptional network in prostate cancer.
    Cancer Res. 2008;68:1988-96.
    PubMed     Related articles    Abstract available
    
    
    
16. LI H , Chen X, Calhoun-Davis T, Claypool K, et al
    PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells.
    Cancer Res. 2008;68:1820-5.
    PubMed     Related articles    Abstract available
    
    
    
17. KUMAR B , Koul S, Khandrika L, Meacham RB, et al
    Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype.
    Cancer Res. 2008;68:1777-85.
    PubMed     Related articles    Abstract available
    
    
    
18. JAMIESON WL , Shimizu S, D'Ambrosio JA, Meucci O, et al
    CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: potential role in prostate cancer bone tropism.
    Cancer Res. 2008;68:1715-22.
    PubMed     Related articles    Abstract available
    
    
    
19. WANG H , Leav I, Ibaragi S, Wegner M, et al
    SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion.
    Cancer Res. 2008;68:1625-30.
    PubMed     Related articles    Abstract available
    
    
    
20. KONG D , Banerjee S, Huang W, Li Y, et al
    Mammalian target of rapamycin repression by 3,3'-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC3 cells.
    Cancer Res. 2008;68:1927-34.
    PubMed     Related articles    Abstract available
    
    
    
21. YI T , Yi Z, Cho SG, Luo J, et al
    Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling.
    Cancer Res. 2008;68:1843-50.
    PubMed     Related articles    Abstract available
    
    
    
22. ZHU A , Zhang CX, Lieberman HB
    Rad9 has a functional role in human prostate carcinogenesis.
    Cancer Res. 2008;68:1267-74.
    PubMed     Related articles    Abstract available
    
    
    February 2008
23. VOLOSHYNA I , Besana A, Castillo M, Matos T, et al
    TREK-1 is a novel molecular target in prostate cancer.
    Cancer Res. 2008;68:1197-203.
    PubMed     Related articles    Abstract available
    
    
    
24. LU M , Xia L, Hua H, Jing Y, et al
    Acetyl-keto-beta-boswellic acid induces apoptosis through a death receptor 5-mediated pathway in prostate cancer cells.
    Cancer Res. 2008;68:1180-6.
    PubMed     Related articles    Abstract available
    
    
    
25. HARA T , Miyazaki H, Lee A, Tran CP, et al
    Androgen receptor and invasion in prostate cancer.
    Cancer Res. 2008;68:1128-35.
    PubMed     Related articles    Abstract available
    
    
    
26. NAJY AJ , Day KC, Day ML
    ADAM15 supports prostate cancer metastasis by modulating tumor cell-endothelial cell interaction.
    Cancer Res. 2008;68:1092-9.
    PubMed     Related articles    Abstract available
    
    
    
27. GRAVES CW , Philips ST, Bradley SV, Oravecz-Wilson KI, et al
    Use of a cryptic splice site for the expression of huntingtin interacting protein 1 in select normal and neoplastic tissues.
    Cancer Res. 2008;68:1064-73.
    PubMed     Related articles    Abstract available
    
    
    
28. WALLACE TA , Prueitt RL, Yi M, Howe TM, et al
    Tumor immunobiological differences in prostate cancer between African-American and European-American men.
    Cancer Res. 2008;68:927-36.
    PubMed     Related articles    Abstract available
    
    
    
29. GARCIA-HERNANDEZ MDE L , Gray A, Hubby B, Klinger OJ, et al
    Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity.
    Cancer Res. 2008;68:861-9.
    PubMed     Related articles    Abstract available
    
    
    
30. TAHIR SA , Yang G, Goltsov AA, Watanabe M, et al
    Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer.
    Cancer Res. 2008;68:731-9.
    PubMed     Related articles    Abstract available
    
    
    
31. LAXMAN B , Morris DS, Yu J, Siddiqui J, et al
    A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer.
    Cancer Res. 2008;68:645-9.
    PubMed     Related articles    Abstract available
    
    
    
32. ARAP W , Trepel M, Zetter BR, Pasqualini R, et al
    Meeting report: innovations in prostate cancer research.
    Cancer Res. 2008;68:635-8.
    PubMed     Related articles   
    
    
    January 2008
33. EBOS JM , Lee CR, Bogdanovic E, Alami J, et al
    Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
    Cancer Res. 2008;68:521-9.
    PubMed     Related articles    Abstract available
    
    
    
34. SARFARAZ S , Adhami VM, Syed DN, Afaq F, et al
    Cannabinoids for cancer treatment: progress and promise.
    Cancer Res. 2008;68:339-42.
    PubMed     Related articles    Abstract available
    
    
    
35. DEGL'INNOCENTI E , Grioni M, Capuano G, Jachetti E, et al
    Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cells.
    Cancer Res. 2008;68:292-300.
    PubMed     Related articles    Abstract available
    
    
    
36. TAN SH , Dagvadorj A, Shen F, Gu L, et al
    Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells.
    Cancer Res. 2008;68:236-48.
    PubMed     Related articles    Abstract available
    
    
    
37. YANG S , Pham LK, Liao CP, Frenkel B, et al
    A novel bone morphogenetic protein signaling in heterotypic cell interactions in prostate cancer.
    Cancer Res. 2008;68:198-205.
    PubMed     Related articles    Abstract available
    
    
    
38. GLUNDE K , Shah T, Winnard PT Jr, Raman V, et al
    Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1 alpha signaling in a human prostate cancer model.
    Cancer Res. 2008;68:172-80.
    PubMed     Related articles    Abstract available
    
    
    
39. NIE D , Guo Y, Yang D, Tang Y, et al
    Thromboxane A2 receptors in prostate carcinoma: expression and its role in regulating cell motility via small GTPase Rho.
    Cancer Res. 2008;68:115-21.
    PubMed     Related articles    Abstract available
    
    
    
40. HELGESON BE , Tomlins SA, Shah N, Laxman B, et al
    Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.
    Cancer Res. 2008;68:73-80.
    PubMed     Related articles    Abstract available
    
    
    December 2007
41. KOTTKE T , Sanchez-Perez L, Diaz RM, Thompson J, et al
    Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer.
    Cancer Res. 2007;67:11970-9.
    PubMed     Related articles    Abstract available
    
    
    
42. GRAY PJ JR , Stevenson MA, Calderwood SK
    Targeting Cdc37 inhibits multiple signaling pathways and induces growth arrest in prostate cancer cells.
    Cancer Res. 2007;67:11942-50.
    PubMed     Related articles    Abstract available
    
    
    
43. GANGULY A , Das B, Roy A, Sen N, et al
    Betulinic acid, a catalytic inhibitor of topoisomerase I, inhibits reactive oxygen species-mediated apoptotic topoisomerase I-DNA cleavable complex formation in prostate cancer cells but does not affect the process of cell death.
    Cancer Res. 2007;67:11848-58.
    PubMed     Related articles    Abstract available
    
    
    
44. O'CALLAGHAN-SUNOL C , Gabai VL, Sherman MY
    Hsp27 modulates p53 signaling and suppresses cellular senescence.
    Cancer Res. 2007;67:11779-88.
    PubMed     Related articles    Abstract available
    
    
    
45. QUANN EJ , Khwaja F, Djakiew D
    The p38 MAPK pathway mediates aryl propionic acid induced messenger rna stability of p75 NTR in prostate cancer cells.
    Cancer Res. 2007;67:11402-10.
    PubMed     Related articles    Abstract available
    
    
    
46. CRETON SK , Zhu H, Gooderham NJ
    The cooked meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine activates the extracellular signal regulated kinase mitogen-activated protein kinase pathway.
    Cancer Res. 2007;67:11455-62.
    PubMed     Related articles    Abstract available
    
    
    
47. GARRISON JB , Shaw YJ, Chen CS, Kyprianou N, et al
    Novel quinazoline-based compounds impair prostate tumorigenesis by targeting tumor vascularity.
    Cancer Res. 2007;67:11344-52.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    November 2007
48. VILLAR J , Arenas MI, Maccarthy CM, Blanquez MJ, et al
    PCPH/ENTPD5 Expression Enhances the Invasiveness of Human Prostate Cancer Cells by a Protein Kinase C{delta} Dependent Mechanism.
    Cancer Res. 2007;67:10859-10868.
    PubMed     Related articles    Abstract available
    
    
    
49. YU J , Yu J, Rhodes DR, Tomlins SA, et al
    A Polycomb Repression Signature in Metastatic Prostate Cancer Predicts Cancer Outcome.
    Cancer Res. 2007;67:10657-10663.
    PubMed     Related articles    Abstract available
    
    
    
50. RAINA K , Blouin MJ, Singh RP, Majeed N, et al
    Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
    Cancer Res. 2007;67:11083-91.
    PubMed     Related articles    Abstract available
    
    
    
51. KAWAKUBO T , Okamoto K, Iwata J, Shin M, et al
    Cathepsin E prevents tumor growth and metastasis by catalyzing the proteolytic release of soluble TRAIL from tumor cell surface.
    Cancer Res. 2007;67:10869-78.
    PubMed     Related articles    Abstract available
    
    
    
52. THIYAGARAJAN S , Bhatia N, Reagan-Shaw S, Cozma D, et al
    Role of GLI2 transcription factor in growth and tumorigenicity of prostate cells.
    Cancer Res. 2007;67:10642-6.
    PubMed     Related articles    Abstract available
    
    
    
53. HEEMERS HV , Regan KM, Dehm SM, Tindall DJ, et al
    Androgen Induction of the Androgen Receptor Coactivator Four and a Half LIM Domain Protein-2: Evidence for a Role for Serum Response Factor in Prostate Cancer.
    Cancer Res. 2007;67:10592-10599.
    PubMed     Related articles    Abstract available
    
    
    
54. CHEN Y , Tang Y, Wang MT, Zeng S, et al
    Human Pregnane X Receptor and Resistance to Chemotherapy in Prostate Cancer.
    Cancer Res. 2007;67:10361-10367.
    PubMed     Related articles    Abstract available
    
    
    
55. SETLUR SR , Royce TE, Sboner A, Mosquera JM, et al
    Integrative Microarray Analysis of Pathways Dysregulated in Metastatic Prostate Cancer.
    Cancer Res. 2007;67:10296-10303.
    PubMed     Related articles    Abstract available
    
    
    
56. ANDREANI V , Gatti G, Simonella L, Rivero V, et al
    Activation of Toll-like receptor 4 on tumor cells in vitro inhibits subsequent tumor growth in vivo.
    Cancer Res. 2007;67:10519-27.
    PubMed     Related articles    Abstract available
    
    
    
57. ZOUBEIDI A , Zardan A, Beraldi E, Fazli L, et al
    Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity.
    Cancer Res. 2007;67:10455-65.
    PubMed     Related articles    Abstract available
    
    
    
58. SVENSSON RU , Barnes JM, Rokhlin OW, Cohen MB, et al
    Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy.
    Cancer Res. 2007;67:10445-54.
    PubMed     Related articles    Abstract available
    
    
    
59. MORETTI RM , Marelli MM, Mai S, Cariboni A, et al
    Clusterin isoforms differentially affect growth and motility of prostate cells: possible implications in prostate tumorigenesis.
    Cancer Res. 2007;67:10325-33.
    PubMed     Related articles    Abstract available
    
    
    October 2007
60. BUCHANAN G , Ricciardelli C, Harris JM, Prescott J, et al
    Control of Androgen Receptor Signaling in Prostate Cancer by the Cochaperone Small Glutamine Rich Tetratricopeptide Repeat Containing Protein {alpha}.
    Cancer Res. 2007;67:10087-96.
    PubMed     Related articles    Abstract available
    
    
    
61. DEHM SM , Regan KM, Schmidt LJ, Tindall DJ, et al
    Selective Role of an NH2-Terminal WxxLF Motif for Aberrant Androgen Receptor Activation in Androgen Depletion Independent Prostate Cancer Cells.
    Cancer Res. 2007;67:10067-77.
    PubMed     Related articles    Abstract available
    
    
    
62. SALAH Z , Maoz M, Pizov G, Bar-Shavit R, et al
    Transcriptional regulation of human protease-activated receptor 1: a role for the early growth response-1 protein in prostate cancer.
    Cancer Res. 2007;67:9835-43.
    PubMed     Related articles    Abstract available
    
    
    
63. FENTON BM , Paoni SF
    The addition of AG-013736 to fractionated radiation improves tumor response without functionally normalizing the tumor vasculature.
    Cancer Res. 2007;67:9921-8.
    PubMed     Related articles    Abstract available
    
    
    
64. STATHOPOULOS GT , Kollintza A, Moschos C, Psallidas I, et al
    Tumor necrosis factor-alpha promotes malignant pleural effusion.
    Cancer Res. 2007;67:9825-34.
    PubMed     Related articles    Abstract available
    
    
    
65. KELLER ET , Rowley DR, Tomlins SA, Drake CG, et al
    Eleventh Prouts Neck Meeting on Prostate Cancer: Emerging Strategies in Prostate Cancer Therapy.
    Cancer Res. 2007;.
    PubMed     Related articles   
    
    
    
66. ZHANG X , Zhang L, Yang H, Huang X, et al
    c-Fos as a Proapoptotic Agent in TRAIL-Induced Apoptosis in Prostate Cancer Cells.
    Cancer Res. 2007;67:9425-34.
    PubMed     Related articles    Abstract available
    
    
    
67. LOBERG RD , Ying C, Craig M, Day LL, et al
    Targeting CCL2 with Systemic Delivery of Neutralizing Antibodies Induces Prostate Cancer Tumor Regression In vivo.
    Cancer Res. 2007;67:9417-24.
    PubMed     Related articles    Abstract available
    
    
    
68. VARGHESE S , Rabkin SD, Nielsen GP, Macgarvey U, et al
    Systemic therapy of spontaneous prostate cancer in transgenic mice with oncolytic herpes simplex viruses.
    Cancer Res. 2007;67:9371-9.
    PubMed     Related articles    Abstract available
    
    
    
69. KLEEBERGER W , Bova GS, Nielsen ME, Herawi M, et al
    Roles for the stem cell associated intermediate filament nestin in prostate cancer migration and metastasis.
    Cancer Res. 2007;67:9199-206.
    PubMed     Related articles    Abstract available
    
    
    
70. BANACH-PETROSKY W , Jessen WJ, Ouyang X, Gao H, et al
    Prolonged Exposure to Reduced Levels of Androgen Accelerates Prostate Cancer Progression in Nkx3.1; Pten Mutant Mice.
    Cancer Res. 2007;67:9089-9096.
    PubMed     Related articles    Abstract available
    
    
    
71. IMAI M , Ohta R, Varela JC, Song H, et al
    Enhancement of antibody-dependent mechanisms of tumor cell lysis by a targeted activator of complement.
    Cancer Res. 2007;67:9535-41.
    PubMed     Related articles    Abstract available
    
    
    
72. ZHANG Y , Bressler JP, Neal J, Lal B, et al
    ABCG2/BCRP expression modulates D-Luciferin based bioluminescence imaging.
    Cancer Res. 2007;67:9389-97.
    PubMed     Related articles    Abstract available
    
    
    
73. PARK SY , Yu X, Ip C, Mohler JL, et al
    Peroxiredoxin 1 interacts with androgen receptor and enhances its transactivation.
    Cancer Res. 2007;67:9294-303.
    PubMed     Related articles    Abstract available
    
    
    
74. CHEN D , Frezza M, Shakya R, Cui QC, et al
    Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects.
    Cancer Res. 2007;67:9258-65.
    PubMed     Related articles    Abstract available
    
    
    
75. LIBERTINI SJ , Tepper CG, Rodriguez V, Asmuth DM, et al
    Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence.
    Cancer Res. 2007;67:9001-5.
    PubMed     Related articles    Abstract available
    
    
    September 2007
76. PANDINI G , Genua M, Frasca F, Squatrito S, et al
    17{beta}-Estradiol Up-regulates the Insulin-like Growth Factor Receptor through a Nongenotropic Pathway in Prostate Cancer Cells.
    Cancer Res. 2007;67:8932-41.
    PubMed     Related articles    Abstract available
    
    
    
77. ZHANG H , Wang J, Pang B, Liang RX, et al
    PC-1/PrLZ Contributes to Malignant Progression in Prostate Cancer.
    Cancer Res. 2007;67:8906-13.
    PubMed     Related articles    Abstract available
    
    
    
78. AZIZ MH , Manoharan HT, Church DR, Dreckschmidt NE, et al
    Protein Kinase C{varepsilon} Interacts with Signal Transducers and Activators of Transcription 3 (Stat3), Phosphorylates Stat3Ser727, and Regulates Its Constitutive Activation in Prostate Cancer.
    Cancer Res. 2007;67:8828-38.
    PubMed     Related articles    Abstract available
    
    
    
79. LAPOINTE J , Li C, Giacomini CP, Salari K, et al
    Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis.
    Cancer Res. 2007;67:8504-10.
    PubMed     Related articles    Abstract available
    
    
    
80. HUDSON TS , Hartle DK, Hursting SD, Nunez NP, et al
    Inhibition of Prostate Cancer Growth by Muscadine Grape Skin Extract and Resveratrol through Distinct Mechanisms.
    Cancer Res. 2007;67:8396-405.
    PubMed     Related articles    Abstract available
    
    
    
81. HODGSON MC , Astapova I, Hollenberg AN, Balk SP, et al
    Activity of Androgen Receptor Antagonist Bicalutamide in Prostate Cancer Cells Is Independent of NCoR and SMRT Corepressors.
    Cancer Res. 2007;67:8388-95.
    PubMed     Related articles    Abstract available
    
    
    
82. CASAREZ EV , Dunlap-Brown ME, Conaway MR, Amorino GP, et al
    Radiosensitization and Modulation of p44/42 Mitogen-Activated Protein Kinase by 2-Methoxyestradiol in Prostate Cancer Models.
    Cancer Res. 2007;67:8316-24.
    PubMed     Related articles    Abstract available
    
    
    
83. KIM JH , Dhanasekaran SM, Mehra R, Tomlins SA, et al
    Integrative analysis of genomic aberrations associated with prostate cancer progression.
    Cancer Res. 2007;67:8229-39.
    PubMed     Related articles    Abstract available
    
    
    
84. HE Y , Franco OE, Jiang M, Williams K, et al
    Tissue-Specific Consequences of Cyclin D1 Overexpression in Prostate Cancer Progression.
    Cancer Res. 2007;67:8188-8197.
    PubMed     Related articles    Abstract available
    
    
    
85. YU YP , Yu G, Tseng G, Cieply K, et al
    Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis.
    Cancer Res. 2007;67:8043-50.
    PubMed     Related articles    Abstract available
    
    
    
86. MAWJI IA , Simpson CD, Gronda M, Williams MA, et al
    A chemical screen identifies anisomycin as an anoikis sensitizer that functions by decreasing FLIP protein synthesis.
    Cancer Res. 2007;67:8307-15.
    PubMed     Related articles    Abstract available
    
    
    
87. BECKERS A , Organe S, Timmermans L, Scheys K, et al
    Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells.
    Cancer Res. 2007;67:8180-7.
    PubMed     Related articles    Abstract available
    
    
    
88. DEEB KK , Michalowska AM, Yoon CY, Krummey SM, et al
    Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.
    Cancer Res. 2007;67:8065-80.
    PubMed     Related articles    Abstract available
    
    
    
89. NAKAHARA T , Takeuchi M, Kinoyama I, Minematsu T, et al
    YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.
    Cancer Res. 2007;67:8014-21.
    PubMed     Related articles    Abstract available
    
    
    
90. MEHRA R , Han B, Tomlins SA, Wang L, et al
    Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases.
    Cancer Res. 2007;67:7991-5.
    PubMed     Related articles    Abstract available
    
    
    August 2007
91. WENG JR , Tsai CH, Kulp SK, Wang D, et al
    A potent indole-3-carbinol derived antitumor agent with pleiotropic effects on multiple signaling pathways in prostate cancer cells.
    Cancer Res. 2007;67:7815-24.
    PubMed     Related articles    Abstract available
    
    
    
92. KASEB AO , Chinnakannu K, Chen D, Sivanandam A, et al
    Androgen Receptor and E2F-1 Targeted Thymoquinone Therapy for Hormone-Refractory Prostate Cancer.
    Cancer Res. 2007;67:7782-8.
    PubMed     Related articles    Abstract available
    
    
    
93. MUKHOPADHAYA A , Mendecki J, Dong X, Liu L, et al
    Localized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity.
    Cancer Res. 2007;67:7798-806.
    PubMed     Related articles    Abstract available
    
    
    
94. ROTH TJ , Sheinin Y, Lohse CM, Kuntz SM, et al
    B7-H3 Ligand Expression by Prostate Cancer: A Novel Marker of Prognosis and Potential Target for Therapy.
    Cancer Res. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
95. DIELI F , Vermijlen D, Fulfaro F, Caccamo N, et al
    Targeting Human {gamma}{delta} T Cells with Zoledronate and Interleukin-2 for Immunotherapy of Hormone-Refractory Prostate Cancer.
    Cancer Res. 2007;67:7450-7.
    PubMed     Related articles    Abstract available
    
    
    
96. SINGH SV , Choi S, Zeng Y, Hahm ER, et al
    Guggulsterone-Induced Apoptosis in Human Prostate Cancer Cells Is Caused by Reactive Oxygen Intermediate Dependent Activation of c-Jun NH2-Terminal Kinase.
    Cancer Res. 2007;67:7439-49.
    PubMed     Related articles    Abstract available
    
    
    
97. LIAO CP , Zhong C, Saribekyan G, Bading J, et al
    Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence.
    Cancer Res. 2007;67:7525-33.
    PubMed     Related articles    Abstract available
    
    
    
98. CLAYTON A , Mitchell JP, Court J, Mason MD, et al
    Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2.
    Cancer Res. 2007;67:7458-66.
    PubMed     Related articles    Abstract available
    
    
    July 2007
99. ARAKI S , Omori Y, Lyn D, Singh RK, et al
    Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer.
    Cancer Res. 2007;67:6854-62.
    PubMed     Related articles    Abstract available
    
    
    
100. PATRAWALA L , Calhoun-Davis T, Schneider-Broussard R, Tang DG, et al
     Hierarchical Organization of Prostate Cancer Cells in Xenograft Tumors: The CD44+{alpha}2{beta}1+ Cell Population Is Enriched in Tumor-Initiating Cells.
     Cancer Res. 2007;67:6796-805.
     PubMed     Related articles    Abstract available
     
     
     
101. HUFFMAN DM , Grizzle WE, Bamman MM, Kim JS, et al
     SIRT1 Is Significantly Elevated in Mouse and Human Prostate Cancer.
     Cancer Res. 2007;67:6612-8.
     PubMed     Related articles    Abstract available
     
     
     
102. CHEN N , Ye XC, Chu K, Navone NM, et al
     A Secreted Isoform of ErbB3 Promotes Osteonectin Expression in Bone and Enhances the Invasiveness of Prostate Cancer Cells.
     Cancer Res. 2007;67:6544-8.
     PubMed     Related articles    Abstract available
     
     
     
103. SHEN MM , Abate-Shen C
     Pten inactivation and the emergence of androgen-independent prostate cancer.
     Cancer Res. 2007;67:6535-8.
     PubMed     Related articles    Abstract available
     
     
     
104. SHUKLA S , MacLennan GT, Flask CA, Fu P, et al
     Blockade of beta-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice.
     Cancer Res. 2007;67:6925-35.
     PubMed     Related articles    Abstract available
     
     
     
105. PULUKURI SM , Rao JS
     Small interfering RNA directed reversal of urokinase plasminogen activator demethylation inhibits prostate tumor growth and metastasis.
     Cancer Res. 2007;67:6637-46.
     PubMed     Related articles    Abstract available
     
     
     
106. REGE K , Patel SJ, Megeed Z, Yarmush ML, et al
     Amphipathic peptide-based fusion peptides and immunoconjugates for the targeted ablation of prostate cancer cells.
     Cancer Res. 2007;67:6368-75.
     PubMed     Related articles    Abstract available
     
     
     
107. DAN HC , Adli M, Baldwin AS
     Regulation of mammalian target of rapamycin activity in PTEN-inactive prostate cancer cells by I kappa B kinase alpha.
     Cancer Res. 2007;67:6263-9.
     PubMed     Related articles    Abstract available
     
     
     
108. SHARMA A , Comstock CE, Knudsen ES, Cao KH, et al
     Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells.
     Cancer Res. 2007;67:6192-203.
     PubMed     Related articles    Abstract available
     
     
     
109. SIZEMORE S , Cicek M, Sizemore N, Ng KP, et al
     Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin.
     Cancer Res. 2007;67:6183-91.
     PubMed     Related articles    Abstract available
     
     
     
110. VALENZUELA HF , Pace KE, Cabrera PV, White R, et al
     O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1.
     Cancer Res. 2007;67:6155-62.
     PubMed     Related articles    Abstract available
     
     
     
111. PORKKA KP , Pfeiffer MJ, Waltering KK, Vessella RL, et al
     MicroRNA expression profiling in prostate cancer.
     Cancer Res. 2007;67:6130-5.
     PubMed     Related articles    Abstract available
     
     
     
112. JIAO J , Wang S, Qiao R, Vivanco I, et al
     Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development.
     Cancer Res. 2007;67:6083-91.
     PubMed     Related articles    Abstract available
     
     
     
113. MILOSEVIC M , Chung P, Parker C, Bristow R, et al
     Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation response.
     Cancer Res. 2007;67:6022-5.
     PubMed     Related articles    Abstract available
     
     
     
114. ADAM RM , Mukhopadhyay NK, Kim J, Di Vizio D, et al
     Cholesterol sensitivity of endogenous and myristoylated Akt.
     Cancer Res. 2007;67:6238-46.
     PubMed     Related articles    Abstract available
     
     
     June 2007
115. CHUNG AC , Zhou S, Liao L, Tien JC, et al
     Genetic Ablation of the Amplified-in-Breast Cancer 1 Inhibits Spontaneous Prostate Cancer Progression in Mice.
     Cancer Res. 2007;67:5965-75.
     PubMed     Related articles    Abstract available
     
     
     
116. ISAYEVA T , Chanda D, Kallman L, Eltoum IE, et al
     Effects of Sustained Antiangiogenic Therapy in Multistage Prostate Cancer in TRAMP Model.
     Cancer Res. 2007;67:5789-97.
     PubMed     Related articles    Abstract available
     
     
     
117. LIU XH , Kirschenbaum A, Yao S, Liu G, et al
     Androgen-Induced Wnt Signaling in Preosteoblasts Promotes the Growth of MDA-PCa-2b Human Prostate Cancer Cells.
     Cancer Res. 2007;67:5747-53.
     PubMed     Related articles    Abstract available
     
     
     
118. VERONA EV , Elkahloun AG, Yang J, Bandyopadhyay A, et al
     Transforming Growth Factor-{beta} Signaling in Prostate Stromal Cells Supports Prostate Carcinoma Growth by Up-regulating Stromal Genes Related to Tissue Remodeling.
     Cancer Res. 2007;67:5737-46.
     PubMed     Related articles    Abstract available
     
     
     
119. RAINA K , Singh RP, Agarwal R, Agarwal C, et al
     Oral grape seed extract inhibits prostate tumor growth and progression in TRAMP mice.
     Cancer Res. 2007;67:5976-82.
     PubMed     Related articles    Abstract available
     
     
     
120. ZHANG L , Gao L, Zhao L, Guo B, et al
     Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid-based small interfering RNAs.
     Cancer Res. 2007;67:5859-64.
     PubMed     Related articles    Abstract available
     
     
     
121. CHALLITA-EID PM , Morrison K, Etessami S, An Z, et al
     Monoclonal antibodies to six-transmembrane epithelial antigen of the prostate-1 inhibit intercellular communication in vitro and growth of human tumor xenografts in vivo.
     Cancer Res. 2007;67:5798-805.
     PubMed     Related articles    Abstract available
     
     
     
122. ZHOU Z , Flesken-Nikitin A, Nikitin AY
     Prostate Cancer Associated with p53 and Rb Deficiency Arises from the Stem/Progenitor Cell-Enriched Proximal Region of Prostatic Ducts.
     Cancer Res. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
123. CHEN CS , Wang YC, Yang HC, Huang PH, et al
     Histone Deacetylase Inhibitors Sensitize Prostate Cancer Cells to Agents that Produce DNA Double-Strand Breaks by Targeting Ku70 Acetylation.
     Cancer Res. 2007;67:5318-27.
     PubMed     Related articles    Abstract available
     
     
     
124. KLOKK TI , Kilander A, Xi Z, Waehre H, et al
     Kallikrein 4 Is a Proliferative Factor that Is Overexpressed in Prostate Cancer.
     Cancer Res. 2007;67:5221-5230.
     PubMed     Related articles    Abstract available
     
     
     
125. TAMURA K , Furihata M, Tsunoda T, Ashida S, et al
     Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles.
     Cancer Res. 2007;67:5117-25.
     PubMed     Related articles    Abstract available
     
     
     
126. KOBAYASHI H , Nagato T, Sato K, Aoki N, et al
     Recognition of Prostate and Melanoma Tumor Cells by Six-Transmembrane Epithelial Antigen of Prostate-Specific Helper T Lymphocytes in a Human Leukocyte Antigen Class II-Restricted Manner.
     Cancer Res. 2007;67:5498-504.
     PubMed     Related articles    Abstract available
     
     
     
127. SARKAR D , Lebedeva IV, Su ZZ, Park ES, et al
     Eradication of therapy-resistant human prostate tumors using a cancer terminator virus.
     Cancer Res. 2007;67:5434-42.
     PubMed     Related articles    Abstract available
     
     
     May 2007
128. MOSTAGHEL EA , Page ST, Lin DW, Fazli L, et al
     Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer.
     Cancer Res. 2007;67:5033-41.
     PubMed     Related articles    Abstract available
     
     
     
129. YU S , Wang X, Ng CF, Chen S, et al
     ERR{gamma} Suppresses Cell Proliferation and Tumor Growth of Androgen-Sensitive and Androgen-Insensitive Prostate Cancer Cells and Its Implication as a Therapeutic Target for Prostate Cancer.
     Cancer Res. 2007;67:4904-14.
     PubMed     Related articles    Abstract available
     
     
     
130. GU G , Yuan J, Wills M, Kasper S, et al
     Prostate Cancer Cells with Stem Cell Characteristics Reconstitute the Original Human Tumor In vivo.
     Cancer Res. 2007;67:4807-15.
     PubMed     Related articles    Abstract available
     
     
     
131. TILLMAN JE , Yuan J, Gu G, Fazli L, et al
     DJ-1 Binds Androgen Receptor Directly and Mediates Its Activity in Hormonally Treated Prostate Cancer Cells.
     Cancer Res. 2007;67:4630-7.
     PubMed     Related articles    Abstract available
     
     
     
132. REICHARDT JK , Tilley WD
     The 3rd pacific rim meeting on breast and prostate cancer: progress in hormonal carcinogenesis and the enduring influence of ron ross.
     Cancer Res. 2007;67:4550-2.
     PubMed     Related articles   
     
     
     
133. GU X , Zerbini LF, Otu HH, Bhasin M, et al
     Reduced PDEF Expression Increases Invasion and Expression of Mesenchymal Genes in Prostate Cancer Cells.
     Cancer Res. 2007;67:4219-26.
     PubMed     Related articles    Abstract available
     
     
     
134. CHANG BL , Liu W, Sun J, Dimitrov L, et al
     Integration of somatic deletion analysis of prostate cancers and germline linkage analysis of prostate cancer families reveals two small consensus regions for prostate cancer genes at 8p.
     Cancer Res. 2007;67:4098-103.
     PubMed     Related articles    Abstract available
     
     
     
135. VIJAYVARGIA R , May MS, Fondell JD
     A Coregulatory Role for the Mediator Complex in Prostate Cancer Cell Proliferation and Gene Expression.
     Cancer Res. 2007;67:4034-4041.
     PubMed     Related articles    Abstract available
     
     
     
136. HAELENS A , Tanner T, Denayer S, Callewaert L, et al
     The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor.
     Cancer Res. 2007;67:4514-23.
     PubMed     Related articles    Abstract available
     
     
     
137. GANESH S , Gonzalez Edick M, Idamakanti N, Abramova M, et al
     Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice.
     Cancer Res. 2007;67:4399-407.
     PubMed     Related articles    Abstract available
     
     
     
138. CASIMIRO M , Rodriguez O, Pootrakul L, Aventian M, et al
     ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo.
     Cancer Res. 2007;67:4364-72.
     PubMed     Related articles    Abstract available
     
     
     
139. AO M , Franco OE, Park D, Raman D, et al
     Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
     Cancer Res. 2007;67:4244-53.
     PubMed     Related articles    Abstract available
     
     
     April 2007
140. BANERJEE S , Hussain M, Wang Z, Saliganan A, et al
     In vitro and In vivo Molecular Evidence for Better Therapeutic Efficacy of ABT-627 and Taxotere Combination in Prostate Cancer.
     Cancer Res. 2007;67:3818-26.
     PubMed     Related articles    Abstract available
     
     
     
141. DEEBLE PD , Cox ME, Frierson HF Jr, Sikes RA, et al
     Androgen-Independent Growth and Tumorigenesis of Prostate Cancer Cells Are Enhanced by the Presence of PKA-Differentiated Neuroendocrine Cells.
     Cancer Res. 2007;67:3663-72.
     PubMed     Related articles    Abstract available
     
     
     
142. LU Y , Cai Z, Xiao G, Keller ET, et al
     Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption.
     Cancer Res. 2007;67:3646-53.
     PubMed     Related articles    Abstract available
     
     
     
143. LEE KC , Sud S, Meyer CR, Moffat BA, et al
     An Imaging Biomarker of Early Treatment Response in Prostate Cancer that Has Metastasized to the Bone.
     Cancer Res. 2007;67:3524-8.
     PubMed     Related articles    Abstract available
     
     
     
144. TSAI MH , Cook JA, Chandramouli GV, Degraff W, et al
     Gene Expression Profiling of Breast, Prostate, and Glioma Cells following Single versus Fractionated Doses of Radiation.
     Cancer Res. 2007;67:3845-52.
     PubMed     Related articles    Abstract available
     
     
     
145. CHOI KJ , Piao YJ, Lim MJ, Kim JH, et al
     Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death.
     Cancer Res. 2007;67:3654-62.
     PubMed     Related articles    Abstract available
     
     
     
146. HEEMERS HV , Sebo TJ, Debes JD, Regan KM, et al
     Androgen Deprivation Increases p300 Expression in Prostate Cancer Cells.
     Cancer Res. 2007;67:3422-30.
     PubMed     Related articles    Abstract available
     
     
     
147. KONG D , Li Y, Wang Z, Banerjee S, et al
     Inhibition of Angiogenesis and Invasion by 3,3'-Diindolylmethane Is Mediated by the Nuclear Factor-{kappa}B Downstream Target Genes MMP-9 and uPA that Regulated Bioavailability of Vascular Endothelial Growth Factor in Prostate Cancer.
     Cancer Res. 2007;67:3310-9.
     PubMed     Related articles    Abstract available
     
     
     
148. MIKI J , Furusato B, Li H, Gu Y, et al
     Identification of Putative Stem Cell Markers, CD133 and CXCR4, in hTERT-Immortalized Primary Nonmalignant and Malignant Tumor-Derived Human Prostate Epithelial Cell Lines and in Prostate Cancer Specimens.
     Cancer Res. 2007;67:3153-61.
     PubMed     Related articles    Abstract available
     
     
     
149. WANG L , McDonnell SK, Slusser JP, Hebbring SJ, et al
     Two common chromosome 8q24 variants are associated with increased risk for prostate cancer.
     Cancer Res. 2007;67:2944-50.
     PubMed     Related articles    Abstract available
     
     
     
150. PLATZ EA
     Genetic variation at 8q24 as a susceptibility factor for prostate cancer: definitive results from epidemiologic studies?
     Cancer Res. 2007;67:2905-7.
     PubMed     Related articles   
     
     
     
151. QUANN EJ , Khwaja F, Zavitz KH, Djakiew D, et al
     The aryl propionic acid R-flurbiprofen selectively induces p75NTR-dependent decreased survival of prostate tumor cells.
     Cancer Res. 2007;67:3254-62.
     PubMed     Related articles    Abstract available
     
     
     
152. YANG CC , Wang YC, Wei S, Lin LF, et al
     Peroxisome proliferator-activated receptor gamma-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation.
     Cancer Res. 2007;67:3229-38.
     PubMed     Related articles    Abstract available
     
     
     
153. SCHUMACHER FR , Feigelson HS, Cox DG, Haiman CA, et al
     A Common 8q24 Variant in Prostate and Breast Cancer from a Large Nested Case-Control Study.
     Cancer Res. 2007;67:2951-2956.
     PubMed     Related articles    Abstract available
     
     
     March 2007
154. MURPHY AJ , Hughes CA, Barrett C, Magee H, et al
     Low-Level TOP2A Amplification in Prostate Cancer Is Associated with HER2 Duplication, Androgen Resistance, and Decreased Survival.
     Cancer Res. 2007;67:2893-8.
     PubMed     Related articles    Abstract available
     
     
     
155. XUAN JW , Bygrave M, Jiang H, Valiyeva F, et al
     Functional neoangiogenesis imaging of genetically engineered mouse prostate cancer using three-dimensional power Doppler ultrasound.
     Cancer Res. 2007;67:2830-9.
     PubMed     Related articles    Abstract available
     
     
     
156. CHINTHARLAPALLI S , Papineni S, Ramaiah SK, Safe S, et al
     Betulinic Acid Inhibits Prostate Cancer Growth through Inhibition of Specificity Protein Transcription Factors.
     Cancer Res. 2007;67:2816-23.
     PubMed     Related articles    Abstract available
     
     
     
157. BRUXVOORT KJ , Charbonneau HM, Giambernardi TA, Goolsby JC, et al
     Inactivation of apc in the mouse prostate causes prostate carcinoma.
     Cancer Res. 2007;67:2490-6.
     PubMed     Related articles    Abstract available
     
     
     
158. LI W , Zhang X, Olumi AF
     MG-132 Sensitizes TRAIL-Resistant Prostate Cancer Cells by Activating c-Fos/c-Jun Heterodimers and Repressing c-FLIP(L).
     Cancer Res. 2007;67:2247-55.
     PubMed     Related articles    Abstract available
     
     
     
159. RAFFOUL JJ , Banerjee S, Singh-Gupta V, Knoll ZE, et al
     Down-regulation of Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 Expression by Soy Isoflavones Enhances Prostate Cancer Radiotherapy In vitro and In vivo.
     Cancer Res. 2007;67:2141-9.
     PubMed     Related articles    Abstract available
     
     
     
160. RAJA GABAGLIA C , Diaz de Durana Y, Graham FL, Gauldie J, et al
     Attenuation of the glucocorticoid response during Ad5IL-12 adenovirus vector treatment enhances natural killer cell-mediated killing of MHC class I-negative LNCaP prostate tumors.
     Cancer Res. 2007;67:2290-7.
     PubMed     Related articles    Abstract available
     
     
     
161. POSPISIL P , Wang K, Al Aowad AF, Iyer LK, et al
     Computational modeling and experimental evaluation of a novel prodrug for targeting the extracellular space of prostate tumors.
     Cancer Res. 2007;67:2197-205.
     PubMed     Related articles    Abstract available
     
     
     
162. LI M , Zhang Z, Hill DL, Wang H, et al
     Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway.
     Cancer Res. 2007;67:1988-96.
     PubMed     Related articles    Abstract available
     
     
     February 2007
163. CHEN D , Cui QC, Yang H, Barrea RA, et al
     Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts.
     Cancer Res. 2007;67:1636-44.
     PubMed     Related articles    Abstract available
     
     
     
164. BIRLE DC , Hedley DW
     Suppression of the hypoxia-inducible factor-1 response in cervical carcinoma xenografts by proteasome inhibitors.
     Cancer Res. 2007;67:1735-43.
     PubMed     Related articles    Abstract available
     
     
     
165. DAS S , Hahn Y, Nagata S, Willingham MC, et al
     NGEP, a prostate-specific plasma membrane protein that promotes the association of LNCaP cells.
     Cancer Res. 2007;67:1594-601.
     PubMed     Related articles    Abstract available
     
     
     
166. JI Q , Chang L, Stanczyk FZ, Ookhtens M, et al
     Impaired Dihydrotestosterone Catabolism in Human Prostate Cancer: Critical Role of AKR1C2 as a Pre-Receptor Regulator of Androgen Receptor Signaling.
     Cancer Res. 2007;67:1361-9.
     PubMed     Related articles    Abstract available
     
     
     
167. GARCIA-HERNANDEZ MDE L , Gray A, Hubby B, Kast WM, et al
     In vivo Effects of Vaccination with Six-Transmembrane Epithelial Antigen of the Prostate: A Candidate Antigen for Treating Prostate Cancer.
     Cancer Res. 2007;67:1344-51.
     PubMed     Related articles    Abstract available
     
     
     
168. TURLEY RS , Finger EC, Hempel N, How T, et al
     The Type III Transforming Growth Factor-{beta} Receptor as a Novel Tumor Suppressor Gene in Prostate Cancer.
     Cancer Res. 2007;67:1090-8.
     PubMed     Related articles    Abstract available
     
     
     
169. VERRAS M , Lee J, Xue H, Li TH, et al
     The Androgen Receptor Negatively Regulates the Expression of c-Met: Implications for a Novel Mechanism of Prostate Cancer Progression.
     Cancer Res. 2007;67:967-75.
     PubMed     Related articles    Abstract available
     
     
     
170. PULUKURI SM , Estes N, Patel J, Rao JS, et al
     Demethylation-linked activation of urokinase plasminogen activator is involved in progression of prostate cancer.
     Cancer Res. 2007;67:930-9.
     PubMed     Related articles    Abstract available
     
     
     
171. LITTLE JL , Wheeler FB, Fels DR, Koumenis C, et al
     Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells.
     Cancer Res. 2007;67:1262-9.
     PubMed     Related articles    Abstract available
     
     
     
172. NAKAI Y , Nelson WG, De Marzo AM
     The dietary charred meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine acts as both a tumor initiator and promoter in the rat ventral prostate.
     Cancer Res. 2007;67:1378-84.
     PubMed     Related articles    Abstract available
     
     
     January 2007
173. WANG H , McKnight NC, Zhang T, Lu ML, et al
     SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.
     Cancer Res. 2007;67:528-36.
     PubMed     Related articles    Abstract available
     
     
     
174. CANO P , Godoy A, Escamilla R, Dhir R, et al
     Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer.
     Cancer Res. 2007;67:511-9.
     PubMed     Related articles    Abstract available
     
     
     
175. DOLLOFF NG , Russell MR, Loizos N, Fatatis A, et al
     Human bone marrow activates the Akt pathway in metastatic prostate cells through transactivation of the alpha-platelet-derived growth factor receptor.
     Cancer Res. 2007;67:555-62.
     PubMed     Related articles    Abstract available
     
     
     
176. BOWEN C , Stuart A, Ju JH, Tuan J, et al
     NKX3.1 homeodomain protein binds to topoisomerase I and enhances its activity.
     Cancer Res. 2007;67:455-64.
     PubMed     Related articles    Abstract available
     
     
     
177. CANENE-ADAMS K , Lindshield BL, Wang S, Jeffery EH, et al
     Combinations of tomato and broccoli enhance antitumor activity in dunning r3327-h prostate adenocarcinomas.
     Cancer Res. 2007;67:836-43.
     PubMed     Related articles    Abstract available
     
     
     
178. GOLDSTEIN D , Gofrit O, Nyska A, Benita S, et al
     Anti-HER2 cationic immunoemulsion as a potential targeted drug delivery system for the treatment of prostate cancer.
     Cancer Res. 2007;67:269-75.
     PubMed     Related articles    Abstract available
     
     
     
179. WANG J , Wang J, Dai J, Jung Y, et al
     A glycolytic mechanism regulating an angiogenic switch in prostate cancer.
     Cancer Res. 2007;67:149-59.
     PubMed     Related articles    Abstract available
     
     
     
180. BUTCHER NJ , Tetlow NL, Cheung C, Broadhurst GM, et al
     Induction of human arylamine N-acetyltransferase type I by androgens in human prostate cancer cells.
     Cancer Res. 2007;67:85-92.
     PubMed     Related articles    Abstract available
     
     
     
181. HUFFMAN DM , Johnson MS, Watts A, Elgavish A, et al
     Cancer progression in the transgenic adenocarcinoma of mouse prostate mouse is related to energy balance, body mass, and body composition, but not food intake.
     Cancer Res. 2007;67:417-24.
     PubMed     Related articles    Abstract available
     
     
     December 2006
182. SRINIVASAN S , Ranga RS, Burikhanov R, Han SS, et al
     Par-4-Dependent Apoptosis by the Dietary Compound Withaferin A in Prostate Cancer Cells.
     Cancer Res. 2006;.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
183. HESS-WILSON JK , Daly HK, Zagorski WA, Montville CP, et al
     Mitogenic action of the androgen receptor sensitizes prostate cancer cells to taxane-based cytotoxic insult.
     Cancer Res. 2006;66:11998-2008.
     PubMed     Related articles    Abstract available
     
     
     
184. BANDYOPADHYAY S , Wang Y, Zhan R, Pai SK, et al
     The Tumor Metastasis Suppressor Gene Drg-1 Down-regulates the Expression of Activating Transcription Factor 3 in Prostate Cancer.
     Cancer Res. 2006;66:11983-90.
     PubMed     Related articles    Abstract available
     
     
     
185. DAVIS JN , Wojno KJ, Daignault S, Hofer MD, et al
     Elevated E2F1 Inhibits Transcription of the Androgen Receptor in Metastatic Hormone-Resistant Prostate Cancer.
     Cancer Res. 2006;66:11897-906.
     PubMed     Related articles    Abstract available
     
     
     
186. GAVRIELIDES MV , Gonzalez-Guerrico AM, Riobo NA, Kazanietz MG, et al
     Androgens Regulate Protein Kinase C{delta} Transcription and Modulate Its Apoptotic Function in Prostate Cancer Cells.
     Cancer Res. 2006;66:11792-801.
     PubMed     Related articles    Abstract available
     
     
     
187. PELLEY RP , Chinnakannu K, Murthy S, Strickland FM, et al
     Calmodulin-Androgen Receptor (AR) Interaction: Calcium-Dependent, Calpain-Mediated Breakdown of AR in LNCaP Prostate Cancer Cells.
     Cancer Res. 2006;66:11754-62.
     PubMed     Related articles    Abstract available
     
     
     
188. MOREY SR , Smiraglia DJ, James SR, Yu J, et al
     DNA methylation pathway alterations in an autochthonous murine model of prostate cancer.
     Cancer Res. 2006;66:11659-67.
     PubMed     Related articles    Abstract available
     
     
     
189. ZERBINI LF , Czibere A, Wang Y, Correa RG, et al
     A Novel Pathway Involving Melanoma Differentiation Associated Gene-7/Interleukin-24 Mediates Nonsteroidal Anti-inflammatory Drug-Induced Apoptosis and Growth Arrest of Cancer Cells.
     Cancer Res. 2006;66:11922-31.
     PubMed     Related articles    Abstract available
     
     
     
190. GHOSH JC , Dohi T, Raskett CM, Kowalik TF, et al
     Activated checkpoint kinase 2 provides a survival signal for tumor cells.
     Cancer Res. 2006;66:11576-9.
     PubMed     Related articles    Abstract available
     
     
     
191. GONZALEZ-GRONOW M , Cuchacovich M, Llanos C, Urzua C, et al
     Prostate Cancer Cell Proliferation In vitro Is Modulated by Antibodies against Glucose-Regulated Protein 78 Isolated from Patient Serum.
     Cancer Res. 2006;66:11424-31.
     PubMed     Related articles    Abstract available
     
     
     
192. KAHL P , Gullotti L, Heukamp LC, Wolf S, et al
     Androgen Receptor Coactivators Lysine-Specific Histone Demethylase 1 and Four and a Half LIM Domain Protein 2 Predict Risk of Prostate Cancer Recurrence.
     Cancer Res. 2006;66:11341-7.
     PubMed     Related articles    Abstract available
     
     
     November 2006
193. LINDSTROM S , Wiklund F, Adami HO, Balter KA, et al
     Germ-Line Genetic Variation in the Key Androgen-Regulating Genes Androgen Receptor, Cytochrome P450, and Steroid-5-{alpha}-Reductase Type 2 Is Important for Prostate Cancer Development.
     Cancer Res. 2006;66:11077-11083.
     PubMed     Related articles    Abstract available
     
     
     
194. KOSHARSKYY B , Solban N, Chang SK, Rizvi I, et al
     A Mechanism-Based Combination Therapy Reduces Local Tumor Growth and Metastasis in an Orthotopic Model of Prostate Cancer.
     Cancer Res. 2006;66:10953-10958.
     PubMed     Related articles    Abstract available
     
     
     
195. ILAGAN R , Pottratz J, Le K, Zhang L, et al
     Imaging Mitogen-Activated Protein Kinase Function in Xenograft Models of Prostate Cancer.
     Cancer Res. 2006;66:10778-10785.
     PubMed     Related articles    Abstract available
     
     
     
196. HERMANS KG , van Marion R, van Dekken H, Jenster G, et al
     TMPRSS2:ERG Fusion by Translocation or Interstitial Deletion Is Highly Relevant in Androgen-Dependent Prostate Cancer, But Is Bypassed in Late-Stage Androgen Receptor-Negative Prostate Cancer.
     Cancer Res. 2006;66:10658-10663.
     PubMed     Related articles    Abstract available
     
     
     
197. KRAUS S , Gioeli D, Vomastek T, Gordon V, et al
     Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor.
     Cancer Res. 2006;66:11047-54.
     PubMed     Related articles    Abstract available
     
     
     
198. YAN J , Yu CT, Ozen M, Ittmann M, et al
     Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway.
     Cancer Res. 2006;66:11039-46.
     PubMed     Related articles    Abstract available
     
     
     
199. MOHAMEDALI KA , Poblenz AT, Sikes CR, Navone NM, et al
     Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121/rGel.
     Cancer Res. 2006;66:10919-28.
     PubMed     Related articles    Abstract available
     
     
     
200. COBB LJ , Liu B, Lee KW, Cohen P, et al
     Phosphorylation by DNA-dependent protein kinase is critical for apoptosis induction by insulin-like growth factor binding protein-3.
     Cancer Res. 2006;66:10878-84.
     PubMed     Related articles    Abstract available
     
     
     
201. PERK J , Gil-Bazo I, Chin Y, de Candia P, et al
     Reassessment of Id1 Protein Expression in Human Mammary, Prostate, and Bladder Cancers Using a Monospecific Rabbit Monoclonal Anti-Id1 Antibody.
     Cancer Res. 2006;66:10870-10877.
     PubMed     Related articles    Abstract available
     
     
     
202. BETHEL CR , Faith D, Li X, Guan B, et al
     Decreased NKX3.1 Protein Expression in Focal Prostatic Atrophy, Prostatic Intraepithelial Neoplasia, and Adenocarcinoma: Association with Gleason Score and Chromosome 8p Deletion.
     Cancer Res. 2006;66:10683-10690.
     PubMed     Related articles    Abstract available
     
     
     
203. AGOULNIK IU , Vaid A, Nakka M, Alvarado M, et al
     Androgens Modulate Expression of Transcription Intermediary Factor 2, an Androgen Receptor Coactivator whose Expression Level Correlates with Early Biochemical Recurrence in Prostate Cancer.
     Cancer Res. 2006;66:10594-602.
     PubMed     Related articles    Abstract available
     
     
     
204. WANG X , Wang F, Taniguchi K, Seelan RS, et al
     Truncating Variants in p53AIP1 Disrupting DNA Damage-Induced Apoptosis Are Associated with Prostate Cancer Risk.
     Cancer Res. 2006;66:10302-7.
     PubMed     Related articles    Abstract available
     
     
     
205. ILJIN K , Wolf M, Edgren H, Gupta S, et al
     TMPRSS2 Fusions with Oncogenic ETS Factors in Prostate Cancer Involve Unbalanced Genomic Rearrangements and Are Associated with HDAC1 and Epigenetic Reprogramming.
     Cancer Res. 2006;66:10242-6.
     PubMed     Related articles    Abstract available
     
     
     
206. CHENG H , Snoek R, Ghaidi F, Cox ME, et al
     Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression.
     Cancer Res. 2006;66:10613-20.
     PubMed     Related articles    Abstract available
     
     
     
207. ELLWOOD-YEN K , Wongvipat J, Sawyers C
     Transgenic mouse model for rapid pharmacodynamic evaluation of antiandrogens.
     Cancer Res. 2006;66:10513-6.
     PubMed     Related articles    Abstract available
     
     
     
208. DESAI SJ , Ma AH, Tepper CG, Chen HW, et al
     Inappropriate activation of the androgen receptor by nonsteroids: involvement of the Src kinase pathway and its therapeutic implications.
     Cancer Res. 2006;66:10449-59.
     PubMed     Related articles    Abstract available
     
     
     October 2006
209. CAMP NJ , Farnham JM, Cannon-Albright LA
     Localization of a Prostate Cancer Predisposition Gene to an 880-kb Region on Chromosome 22q12.3 in Utah High-Risk Pedigrees.
     Cancer Res. 2006;66:10205-12.
     PubMed     Related articles    Abstract available
     
     
     
210. BHUIYAN MM , Li Y, Banerjee S, Ahmed F, et al
     Down-regulation of Androgen Receptor by 3,3'-Diindolylmethane Contributes to Inhibitio